CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 0	$ 0
Operating Expenses
General and administrative	3,480,010	2,157,745
Research and development	1,665,913	1,023,823
Total Operating Expenses	5,145,923	3,181,568
Operating Loss	(5,145,923)	(3,181,568)
Other Income
Interest income	374,911	361,984
Total Other Income	374,911	361,984
Net Loss Before Income Taxes	(4,771,012)	(2,819,584)
Income taxes	0	0
Net Loss	$ (4,771,012)	$ (2,819,584)
Net Loss Per Common Share
Basic and diluted	$ (0.24)	$ (0.21)
Weighted Average Number of Common Shares Outstanding	19,547,312	13,491,954

No definition available.

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.